The recipients of this year's grants include scientists and clinicians studying Parkinson’s biology, brain networks, and symptoms.| Parkinson's News Today
Parkinson’s patients and their care partners found several aspects of a personalized fall prevention program effective, despite barriers.| Parkinson's News Today
Seal Rock has joined an MJFF initiative to develop therapies targeting the LRRK2 gene, which can contribute to Parkinson’s development.| Parkinson's News Today
Having metabolic syndrome, a cluster of abnormalities characterized by abdominal obesity and high blood sugar, may increase Parkinson's risk.| Parkinson's News Today
Expanding access to specialist healthcare for Parkinson's is increasingly urgent as the number of patients rise in the U.S., researchers say.| Parkinson's News Today
Analyzing real-world patient data may help researchers better understand Parkinson’s causes, its early signs, and responses to therapy.| Parkinson's News Today
ENERGI-F705PD, a potential disease-modifying therapy for Parkinson’s, was found safe and well tolerated in healthy volunteers in a trial.| Parkinson's News Today
In a mouse model of Parkinson’s, continuous exposure to low-oxygen air eased or even reversed motor symptoms and slowed disease progression.| Parkinson's News Today
Parkinson's patients receiving brain stem cell transplant therapy may be able to take a less intensive immunosuppression regimen.| Parkinson's News Today
Insilico said it plans to ask the FDA this year for permission to move an AI-designed Parkinson's therapy into clinical trials.| Parkinson's News Today
Lila is a Science Writer at BioNews. She completed her PhD in neuroscience at the University of Washington, where she studied how the natural flexibility of the human brain can be used to promote recovery after injury. Previously, she has written about science for The Dallas Morning News and the...| Parkinson's News Today
Category archive page for News.| Parkinson's News Today